| Title |
AVAglio: Phase 3 trial of bevacizumab plus temozolomide and radiotherapy in newly diagnosed glioblastoma multiforme
|
|---|---|
| Published in |
Advances in Therapy, March 2011
|
| DOI | 10.1007/s12325-011-0007-3 |
| Pubmed ID | |
| Authors |
O. L. Chinot, T. de La Motte Rouge, N. Moore, A. Zeaiter, A. Das, H. Phillips, Z. Modrusan, T. Cloughesy |
Mendeley readers
The data shown below were compiled from readership statistics for 151 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Germany | 2 | 1% |
| United States | 2 | 1% |
| Ecuador | 2 | 1% |
| Hong Kong | 1 | <1% |
| Japan | 1 | <1% |
| Brazil | 1 | <1% |
| Unknown | 142 | 94% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 40 | 26% |
| Student > Ph. D. Student | 24 | 16% |
| Other | 17 | 11% |
| Student > Master | 14 | 9% |
| Student > Bachelor | 11 | 7% |
| Other | 27 | 18% |
| Unknown | 18 | 12% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 68 | 45% |
| Agricultural and Biological Sciences | 24 | 16% |
| Biochemistry, Genetics and Molecular Biology | 8 | 5% |
| Neuroscience | 7 | 5% |
| Nursing and Health Professions | 3 | 2% |
| Other | 12 | 8% |
| Unknown | 29 | 19% |
Attention Score in Context
This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 October 2019.
All research outputs
#5,611,796
of 25,837,817 outputs
Outputs from Advances in Therapy
#551
of 2,677 outputs
Outputs of similar age
#26,897
of 122,752 outputs
Outputs of similar age from Advances in Therapy
#4
of 15 outputs
Altmetric has tracked 25,837,817 research outputs across all sources so far. Compared to these this one has done well and is in the 75th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,677 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.1. This one has done well, scoring higher than 78% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 122,752 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 71% of its contemporaries.
We're also able to compare this research output to 15 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 60% of its contemporaries.